Gastric Cancer
ROSETTA Gastric-204: A Blinded, Randomized, Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Nivolumab in Combination with Chemotherapy in Participants with Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma - CA266-0004
- Details
ClinicalTrials.gov ID:
NCT07221149
Diagnosis Type:
NA
USOR Number:
- Address
,
P: